30 years of historical data (1996–2025) · Healthcare · Biotechnology
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
XOMA Royalty Corp. trades at 28.7x earnings, 14% above its 5-year average of 25.1x, sitting at the 20th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 30%. On a free-cash-flow basis, the stock trades at 183.0x P/FCF, 10% above the 5-year average of 166.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $525M | $478M | $308M | $212M | $210M | $254M | $508M | $239M | $106M | $284M | $25M |
| Enterprise Value | $574M | $527M | $325M | $183M | $152M | $161M | $445M | $215M | $83M | $255M | $43M |
| P/E Ratio → | 28.69 | 18.21 | — | — | — | 32.08 | 56.58 | — | — | 48.77 | — |
| P/S Ratio | 10.07 | 9.17 | 10.79 | 44.60 | 34.84 | 6.66 | 17.28 | 13.02 | 19.99 | 5.39 | 4.57 |
| P/B Ratio | 7.25 | 4.60 | 3.75 | 2.39 | 1.69 | 1.79 | 5.87 | 5.44 | 5.64 | 49.10 | — |
| P/FCF | 182.98 | 166.54 | — | — | — | — | 57.15 | — | — | 106.08 | — |
| P/OCF | 182.98 | 166.54 | — | — | — | 11.21 | 50.30 | — | — | 105.77 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
XOMA Royalty Corp.'s enterprise value stands at 40.0x EBITDA, 75% above its 5-year average of 22.9x. The Healthcare sector median is 14.2x, placing the stock at a 181% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 10.10 | 11.41 | 38.54 | 25.25 | 4.22 | 15.13 | 11.73 | 15.59 | 4.84 | 7.70 |
| EV / EBITDA | 39.98 | 36.69 | — | — | — | 9.10 | 35.32 | — | — | 14.72 | — |
| EV / EBIT | 50.42 | 11.75 | — | — | — | 9.85 | 32.60 | — | — | 14.59 | — |
| EV / FCF | — | 183.49 | — | — | — | — | 50.06 | — | — | 95.29 | — |
Margins and return-on-capital ratios measuring operating efficiency
XOMA Royalty Corp. earns an operating margin of 21.8%. Operating margins have expanded from -879.5% to 21.8% over the past 3 years, signaling improving operational efficiency. Return on equity of 34.1% is exceptionally high. ROIC of 6.8% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 94.3% | 94.3% | 99.3% | 97.0% | 95.5% | 99.6% | 99.4% | 93.2% | 68.3% | 85.1% | 74.8% |
| Operating Margin | 21.8% | 21.8% | -140.3% | -879.5% | -288.9% | 45.9% | 42.3% | -21.1% | -318.1% | 32.3% | -1106.4% |
| Net Profit Margin | 60.8% | 60.8% | -48.5% | -858.2% | -283.8% | 41.4% | 45.3% | -10.8% | -251.8% | 27.7% | -962.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 34.1% | 34.1% | -16.2% | -38.4% | -12.9% | 13.8% | 20.4% | -6.3% | -108.6% | 252.3% | — |
| ROA | 12.8% | 12.8% | -6.1% | -21.8% | -11.1% | 10.8% | 12.0% | -2.5% | -24.5% | 39.7% | -103.4% |
| ROIC | 6.8% | 6.8% | -37.6% | -49.8% | -22.7% | 36.4% | 42.7% | -37.3% | — | — | — |
| ROCE | 5.2% | 5.2% | -19.4% | -24.0% | -12.1% | 13.2% | 12.4% | -5.4% | -35.3% | 101.1% | -257.8% |
Solvency and debt-coverage ratios — lower is generally safer
XOMA Royalty Corp. carries a Debt/EBITDA ratio of 9.2x, which is highly leveraged (185% above the sector average of 3.2x). Net debt stands at $49M ($132M total debt minus $83M cash). Interest coverage of 3.4x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.27 | 1.27 | 1.46 | 1.40 | 0.00 | 0.00 | 0.25 | 0.75 | 1.20 | 2.52 | — |
| Debt / EBITDA | 9.16 | 9.16 | — | — | — | 0.01 | 1.69 | — | — | 0.84 | — |
| Net Debt / Equity | — | 0.47 | 0.21 | -0.33 | -0.47 | -0.66 | -0.73 | -0.54 | -1.24 | -4.99 | — |
| Net Debt / EBITDA | 3.39 | 3.39 | — | — | — | -5.26 | -5.00 | — | — | -1.67 | — |
| Debt / FCF | — | 16.94 | — | — | — | — | -7.09 | — | — | -10.79 | — |
| Interest Coverage | 3.44 | 3.44 | -0.41 | -41.24 | — | 35.47 | 7.40 | -2.02 | -13.62 | 14.13 | -12.57 |
Short-term solvency ratios and asset-utilisation metrics
XOMA Royalty Corp.'s current ratio of 3.37x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 8.68x to 3.37x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.37 | 3.37 | 5.15 | 8.68 | 8.98 | 7.48 | 7.16 | 6.76 | 8.35 | 5.95 | 0.84 |
| Quick Ratio | 3.37 | 3.37 | 5.15 | 8.68 | 8.98 | 7.48 | 7.03 | 6.76 | 8.35 | 5.95 | 0.84 |
| Cash Ratio | 2.39 | 2.39 | 4.32 | 7.87 | 8.53 | 7.26 | 6.85 | 6.39 | 8.03 | 5.86 | 0.79 |
| Asset Turnover | — | 0.19 | 0.13 | 0.02 | 0.04 | 0.23 | 0.23 | 0.19 | 0.08 | 1.17 | 0.19 |
| Inventory Turnover | — | — | — | — | — | — | 0.11 | — | — | — | — |
| Days Sales Outstanding | — | 34.27 | 218.01 | 1167.49 | 143.35 | 2.00 | 22.22 | 58.28 | 101.12 | 2.75 | 37.13 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
XOMA Royalty Corp. returns 3.8% to shareholders annually — split between a 0.7% dividend yield and 3.1% buyback yield. The earnings yield of 3.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.7% | 1.1% | 1.8% | 2.6% | 2.6% | 1.4% | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.5% | 5.5% | — | — | — | 3.1% | 1.8% | — | — | 2.1% | — |
| FCF Yield | 0.5% | 0.6% | — | — | — | — | 1.7% | — | — | 0.9% | — |
| Buyback Yield | 3.1% | 3.4% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 3.8% | 4.5% | 1.8% | 2.6% | 2.6% | 1.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $18M | $12M | $11M | $11M | $12M | $12M | $9M | $8M | $8M | $6M |
Compare XOMA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $525M | 28.7 | 40.0 | 183.0 | 94.3% | 21.8% | 34.1% | 6.8% | 9.2 | |
| $23B | 29.4 | 19.8 | 9.1 | 100.0% | 65.6% | 7.7% | 6.7% | 5.7 | |
| $277M | -1.3 | — | — | 100.0% | -341.3% | -31.2% | — | — | |
| $6B | 17.9 | 10.8 | 13.0 | 75.6% | 56.0% | 48.6% | 31.7% | 1.4 | |
| $2B | -7.4 | — | — | 96.0% | -156.3% | -63.3% | -64.1% | — | |
| $9B | -21.1 | — | — | — | — | -36.7% | -32.5% | — | |
| $8B | -20.9 | — | — | — | — | -45.8% | -65.0% | — | |
| $143B | 18.5 | 10.3 | 15.8 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 | |
| $281B | 15.6 | 10.8 | 22.8 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 | |
| $383B | 91.4 | 15.8 | 21.5 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 | |
| $110B | 15.7 | 8.9 | 8.6 | 67.6% | 26.3% | 40.4% | 16.9% | 2.8 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying XOMA stock.
XOMA Royalty Corp.'s current P/E ratio is 28.7x. The historical average is 41.8x. This places it at the 20th percentile of its historical range.
XOMA Royalty Corp.'s current EV/EBITDA is 40.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 20.3x.
XOMA Royalty Corp.'s return on equity (ROE) is 34.1%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -89.1%.
Based on historical data, XOMA Royalty Corp. is trading at a P/E of 28.7x. This is at the 20th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
XOMA Royalty Corp.'s current dividend yield is 0.73%.
XOMA Royalty Corp. has 94.3% gross margin and 21.8% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
XOMA Royalty Corp.'s Debt/EBITDA ratio is 9.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.